BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9121224)

  • 1. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):677-83. PubMed ID: 9121224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
    Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
    Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron does not block tramadol-induced analgesia in mice.
    Erhan E; Onal A; Kocabas S; Parlar A; Yegul I; Kosay S
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):629-32. PubMed ID: 16357947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of development of tolerance and dependence to opiate in mice by BR-16A (Mentat), a herbal psychotropic preparation.
    Kulkarni SK; Verma A
    Indian J Exp Biol; 1992 Oct; 30(10):885-8. PubMed ID: 1293013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between metoclopramide and morphine: enhanced antinociception and motor dysfunction in rats.
    Kamerman PR; Becker N; Fick LG
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):106-12. PubMed ID: 17201744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
    Naidu PS; Singh A; Joshi D; Kulkarni SK
    Addict Biol; 2003 Sep; 8(3):327-36. PubMed ID: 13129835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of agmatine on tolerance to and substance dependence on morphine in mice.
    Li J; Li X; Pei G; Qin BY
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):232-8. PubMed ID: 10452098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
    Verma A; Kulkarni SK
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):81-7. PubMed ID: 7549459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention by the 5-HT3 receptor antagonist, ondansetron, of morphine-dependence and tolerance in the rat.
    Hui SC; Sevilla EL; Ogle CW
    Br J Pharmacol; 1996 Jun; 118(4):1044-50. PubMed ID: 8799580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquaporin 4 deficiency modulates morphine pharmacological actions.
    Wu N; Lu XQ; Yan HT; Su RB; Wang JF; Liu Y; Hu G; Li J
    Neurosci Lett; 2008 Dec; 448(2):221-5. PubMed ID: 18973795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
    Trang T; Koblic P; Kawaja M; Jhamandas K
    Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors.
    Dogrul A; Ossipov MH; Porreca F
    Brain Res; 2009 Jul; 1280():52-9. PubMed ID: 19427839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
    Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
    Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyanocobalamin (vitamin B12) in the induction and expression of morphine tolerance and dependence in mice.
    Ghazanfari S; Imenshahidi M; Etemad L; Moshiri M; Hosseinzadeh H
    Drug Res (Stuttg); 2014 Mar; 64(3):113-7. PubMed ID: 24105105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine withdrawal modifies antinociceptive effects of acute morphine in rats.
    Dong Z; Mao R; Han H; Cao J; Xu L
    Biochem Biophys Res Commun; 2006 Jul; 346(2):578-82. PubMed ID: 16762316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.